Microsaic Systems PLC Agreement with Unimicro Technologies Inc.

28th March 2018 Microsaic Systems PLC (LON:MSYS), the developer of point of need mass spectrometry (“MS”) instruments, has today announced that it has signed an agreement with Unimicro Technologies Inc. (“Unimicro”)(the “Agreement”). The Agreement covers the integration of Microsaic’s compact 4500 MiD® mass spectrometry detector with Unimicro’s Capillary Electrophoresis (“CE”) Platform. Once integrated, the combined product will be... Read more

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies

Exactis Innovation Selects Ion GeneStudio S5 Systems and Oncomine Assays to Drive Canadian Clinical Trial Studies Laboratory network standardizes on common NGS platform to efficiently profile patient samples across multiple cancer centers CARLSBAD, Calif., March 28, 2018 /PRNewswire/ — At risk cancer patients across Canada may now be able to have their tumors molecularly profiled... Read more

Unchained Labs keeps them coming, acquires rap.ID!

March 27, 2018 – Pleasanton, CA – Unchained Labs, the life sciences company that’s all about getting biologics researchers the right tool for the job, acquired rap.ID today. Rap.ID is a leading provider of systems used for particle identification in biopharmaceutical development and quality control. The company also provides contract services in these areas. This is Unchained Labs’... Read more

MTS Business Partner Opens Testing Innovation Center In Brazil To Support Aerospace Industry Growth

EDEN PRAIRIE, Minn., March 27, 2018 /PRNewswire/ — MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems and sensors, today announced that business partner MTS Sistemas do Brasil Ltda. has opened a new Innovation Center in São Jose dos Campos to better support the Aerospace and Defense industries. São Jose dos Campos... Read more

Agena and Simceredx Announce Strategic Partnership to Develop and Commercialize Companion Diagnostics in China

26 March 2018 San Diego, Calif., and Nanjing, JiangSu, March 26, 2018 – Agena Bioscience (Agena) and Simcere Diagnostics (Simceredx), the subsidiary of SIMCERE Pharmaceutical Group, announced today the signing of a strategic partnership agreement focusing on expanding the use of Agena’s MassARRAY® System for companion diagnostics and pharmacogenetic testing in China. As a leading pharmaceutical... Read more

BIRAC and PerkinElmer Sign Letter of Intent to Promote India-Led Startups and Innovations

NEW DELHI–(BUSINESS WIRE)–The Biotechnology Industry Research Assistance Council (BIRAC) celebrated its 6th Foundation Day on Tuesday in New Delhi. The event, aptly themed ‘Sustaining Innovation: A Market Driven Pathway’, was presided over by the Hon’ble Minister of State for Science and Technology & Earth Sciences, Dr Harsh Vardhan, Prof. Ashutosh Sharma, Secretary, Department of Biotechnology... Read more

Quanterix Corporation and DestiNA Genomics to Collaborate in Effort to Transform microRNA Biomarker Detection

Collaboration offers potential for PCR-free microRNA biomarker detection with high-specificity and ultra-sensitivity March 20, 2018 06:00 AM Pacific Daylight Time LEXINGTON, Mass.–(BUSINESS WIRE)–Quanterix Corporation (NASDAQ:QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced a collaboration with DestiNA Genomics, a manufacturer of patented reagents for nucleic acid detection.... Read more

BD to Divest Remaining Investment in Vyaire Medical to Funds Managed by Apax Partners

FRANKLIN LAKES, N.J., March 19, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it has signed a definitive agreement to divest its remaining, minority stake in Vyaire Medical to funds managed by Apax Partners. According to the terms of the agreement, BD will receive $435... Read more

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification

Thermo Fisher Scientific Acquires IntegenX, Provider of Leading Rapid DNA Technology for Human Identification CARLSBAD, Calif., March 16, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced that it has acquired IntegenX Inc., which provides a rapid DNA platform for use in forensics and law enforcement applications. IntegenX products significantly... Read more